• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amerant Bancorp Announces Appointment of Two New Board Members

    6/24/25 9:20:00 AM ET
    $AMTB
    $BAX
    $WBS
    Major Banks
    Finance
    Medical/Dental Instruments
    Health Care
    Get the next $AMTB alert in real time by email

    Amerant Bancorp Inc. (NYSE:AMTB) ("Amerant" or "the Company") and its subsidiary, Amerant Bank, N.A. (the "Bank"), today announced the appointment of two accomplished executives, Patricia "Patty" Morrison and Jack Kopnisky, to the Board of Directors of the Company and the Bank. Their addition reflects the Company's continued commitment to strategic growth and further strengthening of the Board of Directors and executive management.

    "We are delighted to welcome both Patty and Jack to our Board of Directors," said Jerry Plush, Chairman and CEO of Amerant and the Bank. "Patty's deep technology leadership and extensive board expertise, paired with Jack's enviable experience in leading high performing publicly traded financial services organizations, will be invaluable as we continue to grow and evolve Amerant into Florida's bank of choice. Their insights and guidance will help us achieve our ongoing commitment to delivering long-term value to our customers, shareholders, and communities."

    Patricia "Patty" Morrison is a highly respected information technology executive with a track record of success across multiple Fortune 500 companies. As a former Chief Information Officer of Cardinal Health, she led global technology operations and customer support functions. Her previous leadership roles at Motorola, Office Depot, PepsiCo, and GE reflect her deep expertise in cybersecurity, digital transformation, and large-scale IT execution. With extensive experience serving on the boards of prominent public companies, Patty brings a wealth of knowledge and experience in technology and governance that will support Amerant's innovation and digital transformation. She is currently a member of the Board of Directors of Baxter International Inc. (NYSE:BAX) where she also serves on the Audit and Nominating, Corporate Governance and Public Policy Committees.

    Jack Kopnisky brings more than 40 years of financial services industry leadership experience, having served in senior executive leadership roles at small to midsize banks and financial services companies. Most recently, he was Executive Chairman of Webster Financial Corporation (NYSE:WBS) and Webster Bank, having previously served as CEO of Sterling Bancorp prior to the merger of Sterling with Webster. He also has extensive banking experience from prior leadership roles at Key Bank and Society. His proven expertise in strategy and execution adds additional banking and governance expertise to the Board.

    In addition to Morrison and Kopnisky, Amerant recently added senior leaders Lisa Lutoff-Perlo and Odilon Almeida Júnior to the Board of Directors in January of 2025. All of these recent additions reflect Amerant's commitment to build upon its current board and execute on effective director succession planning.

    About Amerant Bancorp Inc.

    Amerant Bancorp Inc. is a bank holding company headquartered in Coral Gables, Florida since 1979. The Company operates through its subsidiaries, Amerant Bank, N.A. (the "Bank"), Amerant Investments, Inc., and Amerant Mortgage, LLC. The Company provides individuals and businesses with deposit, credit and wealth management services. The Bank, which has operated for over 40 years, is headquartered in Florida and operates 20 banking centers – 19 in South Florida and 1 in Tampa, FL. For more information, visit http://www.investor.amerantbank.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250623257457/en/

    Media:

    Alexis Dominguez

    mediarelations@amerantbank.com

    Investors:

    Laura Rossi

    InvestorRelations@amerantbank.com

    (305) 460-8728

    Get the next $AMTB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTB
    $BAX
    $WBS

    CompanyDatePrice TargetRatingAnalyst
    Baxter International Inc.
    $BAX
    5/28/2026$17.00Neutral → Sell
    Citigroup
    Webster Financial Corporation
    $WBS
    4/7/2026$69.00Neutral
    UBS
    Webster Financial Corporation
    $WBS
    3/3/2026Equal Weight → Underweight
    Wells Fargo
    Baxter International Inc.
    $BAX
    10/31/2025Buy → Hold
    Argus
    Amerant Bancorp Inc.
    $AMTB
    10/29/2025$21.00Mkt Perform → Outperform
    Raymond James
    Webster Financial Corporation
    $WBS
    9/25/2025$78.00Buy
    TD Cowen
    Webster Financial Corporation
    $WBS
    9/10/2025$70.00Overweight
    Cantor Fitzgerald
    Baxter International Inc.
    $BAX
    8/4/2025$25.00Buy → Hold
    Stifel
    More analyst ratings

    $AMTB
    $BAX
    $WBS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $AMTB
    $BAX
    $WBS
    SEC Filings

    View All

    Amerant Bancorp Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Amerant Bancorp Inc. (0001734342) (Filer)

    6/4/26 4:30:14 PM ET
    $AMTB
    Major Banks
    Finance

    Amerant Bancorp Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Amerant Bancorp Inc. (0001734342) (Filer)

    5/29/26 4:30:59 PM ET
    $AMTB
    Major Banks
    Finance

    SEC Form SD filed by Baxter International Inc.

    SD - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    5/29/26 8:28:26 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $AMTB
    $BAX
    $WBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amerant Bancorp Inc. Appoints Carlos Iafigliola as President and CEO

    Amerant Bancorp Inc. (NYSE:AMTB) (the "Company" or "Amerant") today announced that its Board of Directors (the "Board") has appointed Carlos Iafigliola as President and Chief Executive Officer ("President and CEO"), effective May 18, 2026. Mr. Iafigliola has also been appointed President and CEO of Amerant Bank N.A., the Company's main operating subsidiary (the "Bank"). Mr. Iafigliola has served as Interim Chief Executive Officer since November 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519273804/en/Carlos Iafigliola, President and Chief Executive Officer, Amerant Bancorp Inc. Odilon Almeida, Chair of the Board, com

    5/19/26 4:05:00 PM ET
    $AMTB
    Major Banks
    Finance

    4D Path Announces Strategic Financing and Appointment of Katherine Vega Stultz and Robert J. Hombach to Its Board of Directors

    Financing to accelerate 4D Path's pipeline of treatment predictive biomarkers in solid tumors. 4D Path adds two seasoned healthcare executives to strengthen its board and accelerate growth. Ms. Stultz to serve as 4D Path Board Chair 4D Path, a company dedicated to personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy, today announced the first close of a strategic financing round to accelerate the development of treatment predictive biomarkers for 4D Path-sponsored clinical use and partnerships with Biopharma companies. 4D Path's strategy is to develop digital treatment prediction biomarkers that inform more clear and accurate treatmen

    5/5/26 7:00:00 AM ET
    $BAX
    $BMRN
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Baxter Reports First-Quarter 2026 Results

    Sales from continuing operations of $2.7 billion increased 3% on a reported basis and declined 1% on an organic basis1,2 U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($0.03); adjusted diluted EPS from continuing operations of $0.36 Reiterates full-year 2026 financial outlook Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2026. "Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the business, embed a culture of continuous improvement, and strengthen execution," said Andrew Hider, president and CEO. "Although more wo

    4/30/26 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $AMTB
    $BAX
    $WBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Wilson Millar

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    6/4/26 5:47:53 PM ET
    $AMTB
    Major Banks
    Finance

    SEC Form 4 filed by Director Lutoff-Perlo Lisa

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    6/4/26 5:47:42 PM ET
    $AMTB
    Major Banks
    Finance

    SEC Form 4 filed by Director Suarez Oscar

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    6/4/26 5:47:47 PM ET
    $AMTB
    Major Banks
    Finance

    $AMTB
    $BAX
    $WBS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $AMTB
    $BAX
    $WBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Officer Iafigliola Carlos bought $20,177 worth of shares (885 units at $22.80), increasing direct ownership by 4% to 21,576 units (SEC Form 4)

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    4/28/26 4:38:36 PM ET
    $AMTB
    Major Banks
    Finance

    Officer Iafigliola Carlos bought $21,739 worth of shares (1,000 units at $21.74), increasing direct ownership by 7% to 15,964 units (SEC Form 4)

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    1/30/26 5:09:39 PM ET
    $AMTB
    Major Banks
    Finance

    Director Almeida Odilon bought $101,083 worth of shares (4,816 units at $20.99), increasing direct ownership by 963% to 5,316 units (SEC Form 4)

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    1/28/26 5:52:26 PM ET
    $AMTB
    Major Banks
    Finance

    Baxter downgraded by Citigroup with a new price target

    Citigroup downgraded Baxter from Neutral to Sell and set a new price target of $17.00

    5/28/26 8:45:02 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    UBS resumed coverage on Webster Financial with a new price target

    UBS resumed coverage of Webster Financial with a rating of Neutral and set a new price target of $69.00

    4/7/26 8:50:17 AM ET
    $WBS
    Major Banks
    Finance

    Webster Financial downgraded by Wells Fargo

    Wells Fargo downgraded Webster Financial from Equal Weight to Underweight

    3/3/26 1:50:06 PM ET
    $WBS
    Major Banks
    Finance

    $AMTB
    $BAX
    $WBS
    Leadership Updates

    Live Leadership Updates

    View All

    Amerant Bancorp Inc. Appoints Carlos Iafigliola as President and CEO

    Amerant Bancorp Inc. (NYSE:AMTB) (the "Company" or "Amerant") today announced that its Board of Directors (the "Board") has appointed Carlos Iafigliola as President and Chief Executive Officer ("President and CEO"), effective May 18, 2026. Mr. Iafigliola has also been appointed President and CEO of Amerant Bank N.A., the Company's main operating subsidiary (the "Bank"). Mr. Iafigliola has served as Interim Chief Executive Officer since November 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519273804/en/Carlos Iafigliola, President and Chief Executive Officer, Amerant Bancorp Inc. Odilon Almeida, Chair of the Board, com

    5/19/26 4:05:00 PM ET
    $AMTB
    Major Banks
    Finance

    4D Path Announces Strategic Financing and Appointment of Katherine Vega Stultz and Robert J. Hombach to Its Board of Directors

    Financing to accelerate 4D Path's pipeline of treatment predictive biomarkers in solid tumors. 4D Path adds two seasoned healthcare executives to strengthen its board and accelerate growth. Ms. Stultz to serve as 4D Path Board Chair 4D Path, a company dedicated to personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy, today announced the first close of a strategic financing round to accelerate the development of treatment predictive biomarkers for 4D Path-sponsored clinical use and partnerships with Biopharma companies. 4D Path's strategy is to develop digital treatment prediction biomarkers that inform more clear and accurate treatmen

    5/5/26 7:00:00 AM ET
    $BAX
    $BMRN
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    AMERANT BANK APPOINTS TONY EELMAN AS EXECUTIVE VICE PRESIDENT AND CHIEF PRODUCT OFFICER

    Coral Gables, FL, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Amerant Bank, Florida's bank of choice with a growing presence across South Florida, is pleased to announce the appointment of Tony Eelman as EVP, Chief Product Officer. A senior financial services and mortgage-banking executive will now lead enterprise product strategy across the bank's financial services and program-based lending platforms. In his new role, Eelman will focus on aligning product design, leveraging on technology, and progressing our go-to-market strategy to deliver differentiated, client-centric solutions across Amerant's consumer and commercial offerings. "Tony is a leader with a clear vision for how our products

    2/17/26 9:52:38 AM ET
    $AMTB
    Major Banks
    Finance

    $AMTB
    $BAX
    $WBS
    Financials

    Live finance-specific insights

    View All

    Baxter Reports First-Quarter 2026 Results

    Sales from continuing operations of $2.7 billion increased 3% on a reported basis and declined 1% on an organic basis1,2 U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($0.03); adjusted diluted EPS from continuing operations of $0.36 Reiterates full-year 2026 financial outlook Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2026. "Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the business, embed a culture of continuous improvement, and strengthen execution," said Andrew Hider, president and CEO. "Although more wo

    4/30/26 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Webster Financial Corporation Declares Common and Preferred Dividends

    Webster Financial Corporation (NYSE:WBS), the holding company for Webster Bank, N.A., announced that its Board of Directors declared a quarterly cash dividend of $0.40 per share on its common stock. The dividend on common shares will be payable May 21, 2026, to shareholders of record as of May 11, 2026. On its Series F Preferred Stock, Webster declared a quarterly cash dividend of $328.125 per share ($0.328125 per each depositary share, 1,000 of which represent one share of Series F Preferred Stock), payable June 15, 2026, to shareholders of record on May 31, 2026. On its Series G Preferred Stock, Webster declared a quarterly cash dividend of $16.25 per share ($0.40625 per each deposi

    4/29/26 4:15:00 PM ET
    $WBS
    Major Banks
    Finance

    Webster Reports First Quarter 2026 EPS of $1.50; Adjusted EPS of $1.57

    Webster Financial Corporation ("Webster") (NYSE:WBS), the holding company for Webster Bank, N.A., today announced net income applicable to common stockholders of $239.3 million, or $1.50 per diluted share, for the quarter ended March 31, 2026, compared to $220.4 million, or $1.30 per diluted share, for the quarter ended March 31, 2025. First quarter 2026 results include Transaction expenses, strategic restructuring costs, and a benefit related to the FDIC special assessment. Excluding these items, adjusted earnings per diluted share would have been $1.571 for the quarter ended March 31, 2026. On February 3, 2026, Webster entered into a transaction agreement with Banco Santander, S.A. ("

    4/28/26 4:15:00 PM ET
    $WBS
    Major Banks
    Finance

    $AMTB
    $BAX
    $WBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Baxter International Inc.

    SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    11/13/24 1:08:27 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Amerant Bancorp Inc.

    SC 13G/A - Amerant Bancorp Inc. (0001734342) (Subject)

    10/4/24 10:05:58 AM ET
    $AMTB
    Major Banks
    Finance

    SEC Form SC 13G/A filed by Webster Financial Corporation (Amendment)

    SC 13G/A - WEBSTER FINANCIAL CORP (0000801337) (Subject)

    3/11/24 9:59:08 AM ET
    $WBS
    Major Banks
    Finance